Silence Therapeutics plc Share Price OTC Markets
Stocks
SLNCF
GB00B9GTXM62
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
07:26:26 20/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6.370 USD | +1.68% |
|
0.00% | +218.50% |
| 20/10 | Health Care Up on Deal Activity - Health Care Roundup | DJ |
| 20/10 | Silence Therapeutics to Be Acquired by Germany's Merck in $1.3 Billion Deal; Shares Surge | MT |
| Market Cap | 89Cr 119.22Cr 106.79Cr 99Cr 166.71Cr 11TCr 169.4Cr 1.18TCr 468.91Cr 5.94TCr 447.43Cr 437.91Cr 19TCr | P/E 2026 * |
-38.6x | P/E 2027 * | -31.8x |
|---|---|---|---|---|---|
| Enterprise Value | 76Cr 101.25Cr 91Cr 84Cr 141.58Cr 9.64TCr 143.87Cr 998.21Cr 398.23Cr 5.05TCr 379.99Cr 371.9Cr 16TCr | EV / Sales 2026 * |
2,303x | EV / Sales 2027 * | 941x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | +1.68% | ||
| Current month | +59.25% | ||
| 1 month | +59.25% | ||
| 3 months | +324.67% | ||
| 6 months | +169.92% | ||
| Current year | +218.50% |
| 1 month | 3.85 |  | 6.38 |
| Current year | 1.06 | | 6.38 |
| 1 year | 1.06 | | 6.38 |
| 3 years | 0.5 | | 14.75 |
| 5 years | 0.5 | | 46.5 |
| 10 years | 0.5 | | 46.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | 0.00% | - | - | 118.67Cr | |
| +0.34% | -3.03% | +37.45% | +61.06% | 6.41TCr | |
| +0.98% | +2.68% | +12.25% | +83.90% | 5.55TCr | |
| +1.75% | +2.01% | +13.30% | +105.71% | 5.3TCr | |
| -1.84% | -1.66% | +25.64% | +54.49% | 4.6TCr | |
| -0.67% | -3.38% | +17.31% | +97.93% | 4.25TCr | |
| +0.82% | +0.23% | +224.23% | +925.18% | 4.04TCr | |
| -0.26% | -4.20% | +10.86% | +45.18% | 3.23TCr | |
| -2.07% | +42.73% | +103.77% | +90.26% | 3.45TCr | |
| -2.72% | -8.79% | +22.58% | -5.63% | 2.42TCr | |
| Average | -0.23% | +3.82% | +51.93% | +162.01% | 4.36TCr | |
| Weighted average by Cap. | -0.18% | +3.13% | +49.03% | +159.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3L 4L 4L 4L 6L 4.19Cr 6L 43.34L 17.29L 2.19Cr 16.5L 16.15L 6.94Cr | 8L 10.17L 9L 8L 14.22L 9.68Cr 14.45L 1Cr 40L 5.07Cr 38.16L 37.35L 16Cr |
| Net income | -4.26Cr -5.69Cr -5.1Cr -4.7Cr -7.96Cr -542.15Cr -8.09Cr -56Cr -22Cr -283.74Cr -21Cr -21Cr -898.67Cr | -6.49Cr -8.67Cr -7.77Cr -7.17Cr -12Cr -825.93Cr -12Cr -86Cr -34Cr -432.26Cr -33Cr -32Cr -1.37TCr |
| Net Debt | -13Cr -18Cr -16Cr -15Cr -25Cr -1.71TCr -26Cr -177.16Cr -71Cr -895.6Cr -67Cr -66Cr -2.84TCr | -18Cr -24Cr -21Cr -19Cr -33Cr -2.24TCr -33Cr -231.75Cr -92Cr -1.17TCr -88Cr -86Cr -3.71TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | $6.370 | +1.68% | 2,005 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
- SLNCF Stock
Select your edition
All financial news and data tailored to specific country editions
